Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30043792HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043793HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043794HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043795HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043796HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043797HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043798HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043799HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043800HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043801HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TCGA Plot Options
Drug Information
GeneTOP2A
DrugBank IDDB06013
Drug NameAldoxorubicin
Target IDBE0000742
UniProt IDP11388
Regulation Typeinhibitor
PubMed IDs25312684
CitationsChawla SP, Chua VS, Hendifar AF, Quon DV, Soman N, Sankhala KK, Wieland DS, Levitt DJ: A phase 1B/2 study of aldoxorubicin in patients with soft tissue sarcoma. Cancer. 2015 Feb 15;121(4):570-9. doi: 10.1002/cncr.29081. Epub 2014 Oct 13.
GroupsInvestigational
Direct ClassificationAnthracyclines
SMILESCOC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]4C[C@H](N)[C@H](O)[C@H](C)O4)C(CO)=NNC(=O)CCCCCN4C(=O)C=CC4=O)C(O)=C3C(=O)C2=CC=C1
Pathways
PharmGKB
ChEMBLCHEMBL2107818